{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:07:10Z","timestamp":1791670030594,"version":"4.3.4"},"reference-count":121,"publisher":"Tech Science Press","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2024]]},"DOI":"10.32604\/or.2024.052130","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T02:03:24Z","timestamp":1719281004000},"page":"1239-1256","source":"Crossref","is-referenced-by-count":33,"title":["Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in Glioblastoma Multiforme: a systematic review going beyond pathologic implications"],"prefix":"10.32604","volume":"32","author":[{"given":"DIMITRA P.","family":"VAGELI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PANAGIOTIS G.","family":"DOUKAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KERASIA","family":"GOUPOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANTONIOS D.","family":"BENOS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KYRIAKI","family":"ASTARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KONSTANTINA","family":"ZACHAROULI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SOTIRIS","family":"SOTIRIOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARIA","family":"IOANNOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a society for neuro-oncology (SNO) and European society of neuro-oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1215\/S1152851704001115","article-title":"Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis","volume":"7","author":"Kaur","year":"2005","journal-title":"Neuro Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00130404-200305000-00009","article-title":"Long-term survivors of glioblastoma: statistical aberration or important unrecognized molecular subtype?","volume":"9","author":"Senger","year":"2003","journal-title":"Cancer J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.2147\/IJN.S140462","article-title":"Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment","volume":"13","author":"Graham","year":"2018","journal-title":"Int J Nanomed"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-015-1432-1","article-title":"Glioblastoma: pathology, molecular mechanisms and markers","volume":"129","author":"Aldape","year":"2015","journal-title":"Acta Neuropathol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PPO.0b013e318157053f","article-title":"Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme","volume":"13","author":"Fisher","year":"2007","journal-title":"Cancer J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4022960","DOI":"10.1155\/2022\/4022960","article-title":"Genomic and epigenomic features of glioblastoma multiforme and its biomarkers","volume":"2022","author":"Jadoon","year":"2022","journal-title":"J Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/(SICI)1097-0142(19960315)77:6<1161::AID-CNCR24>3.0.CO;2-Z","article-title":"Necrosis as a prognostic factor in glioblastoma multiforme","volume":"77","author":"Barker","year":"1996","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/0008-5472.CAN-03-2073","article-title":"Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population","volume":"64","author":"Brat","year":"2004","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/WCO.0000000000001109","article-title":"The 2021 WHO classification of central nervous system tumors: what neurologists need to know","volume":"35","author":"Jamshidi","year":"2022","journal-title":"Curr Opin Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"TCGA research network. The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.3390\/cancers15194898","article-title":"A narrative review on CD44\u2019s role in glioblastoma invasion, proliferation, and tumor recurrence","volume":"15","author":"Inoue","year":"2023","journal-title":"Cancers"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"11922","DOI":"10.1038\/s41598-020-68733-5","article-title":"Human IDH mutant 1p\/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study","volume":"10","author":"Yao","year":"2020","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"40896","DOI":"10.18632\/oncotarget.5683","article-title":"IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"key":"ref19","first-page":"2867","article-title":"Clinical implications of hypoxia-inducible factor-1\u03b1 and caveolin-1 overexpression in isocitrate dehydrogenase-wild type glioblastoma multiforme","volume":"17","author":"Chen","year":"2019","journal-title":"Oncol Lett"},{"key":"ref20","article-title":"Hypoxia","author":"Bhutta","year":"2024 Jan","journal-title":"StatPearls"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"12608","DOI":"10.3390\/ijms222212608","article-title":"The cornerstone of glioblastoma","volume":"22","author":"Dom\u00e8nech","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/2014.9.FOCUS14496","article-title":"Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma","volume":"37","author":"Womeldorff","year":"2014 Dec","journal-title":"Neurosurg Focus"},{"key":"ref23","first-page":"22073","article-title":"Clinical and prognostic significance of HIF-1\u03b1 in glioma patients: a meta-analysis","volume":"8","author":"Liu","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fncel.2014.00418","article-title":"Gliomas and the vascular fragility of the blood brain barrier","volume":"8","author":"Dubois","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1179\/016164105X39833","article-title":"Expression of VEGF and its receptors in different brain tumors","volume":"27","author":"Huang","year":"2005","journal-title":"Neurol Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s12035-020-01892-8","article-title":"Tumor development and angiogenesis in adult brain tumor: glioblastoma","volume":"57","author":"Ahir","year":"2020","journal-title":"Mol Neurobiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1042\/BST20140278","article-title":"The glioblastoma vasculature as a target for cancer therapy","volume":"42","author":"Dimberg","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.3390\/ijms20246140","article-title":"Hypoxia: Overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes","volume":"20","author":"Tirpe","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e0183516","DOI":"10.1371\/journal.pone.0183516","article-title":"ALK signaling cascade confers multiple advantages to glioblastoma cells through neovascularization and cell proliferation","volume":"12","author":"Chiba","year":"2017","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e0147366","DOI":"10.1371\/journal.pone.0147366","article-title":"Histological characterization of the tumorigenic peri-necrotic niche harboring quiescent stem-like tumor cells in glioblastoma","volume":"11","author":"Ishii","year":"2016","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/092986712803413944","article-title":"Critical role of hypoxia sensor--HIF-1\u03b1 in VEGF gene activation. Implications for angiogenesis and tissue injury healing","volume":"19","author":"Ahluwalia","year":"2012","journal-title":"Curr Med Chem"},{"key":"ref34","first-page":"1399","article-title":"Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A","volume":"9","author":"Lamszus","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12913-014-0579-0","article-title":"PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews","volume":"14","author":"Methley","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA, 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mvr.2008.11.002","article-title":"Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model","volume":"77","author":"Hendriksen","year":"2009","journal-title":"Microvasc Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/00000478-199807000-00004","article-title":"Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma","volume":"22","author":"Chan","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2990.2003.00535.x","article-title":"Hypoxia-inducible factor 1alpha\/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis","volume":"30","author":"Korkolopoulou","year":"2004","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"78541","DOI":"10.18632\/oncotarget.12398","article-title":"Analysis of angiogenesis related factors in glioblastoma, peritumoral tissue and their derived cancer stem cells","volume":"7","author":"D\u2019Alessio","year":"2016","journal-title":"Oncotarget"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1750-3639.2003.tb00013.x","article-title":"Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes","volume":"13","author":"Birner","year":"2003","journal-title":"Brain Pathol"},{"key":"ref42","first-page":"215","article-title":"The effects of 2-hydroxyglutarate on the tumorigenesis of gliomas","volume":"22","author":"Reiter-Brennan","year":"2018","journal-title":"Contemp Oncol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.biopha.2017.02.083","article-title":"IDH mutations associated impact on related cancer epidemiology and subsequent effect toward HIF-1\u03b1","volume":"89","author":"Semukunzi","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"ref44","first-page":"362","article-title":"R132H mutation in IDH1 gene is associated with increased tumor HIF1-Alpha and serum VEGF levels in primary glioblastoma multiforme","volume":"47","author":"Yalaza","year":"2017","journal-title":"Ann Clin Lab Sci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1126\/science.1170944","article-title":"Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha","volume":"324","author":"Zhao","year":"2009","journal-title":"Science"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"16462","DOI":"10.18632\/oncotarget.24536","article-title":"IDH1 mutation is associated with lower expression of VEGF but not microvessel formation in glioblastoma multiforme","volume":"9","author":"Pol\u00edvka","year":"2018","journal-title":"Oncotarget"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.7150\/jca.32909","article-title":"Clinicopathological analysis of HIF-1alpha and TERT on survival outcome in glioblastoma patients: a prospective, single institution study","volume":"10","author":"Potharaju","year":"2019","journal-title":"J Cancer"},{"key":"ref48","author":"Tamimi","journal-title":"Glioblastoma"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12935-021-01920-0","article-title":"MicroRNAs and angiogenesis: a new era for the management of colorectal cancer","volume":"21","author":"Tang","year":"2021","journal-title":"Cancer Cell Int"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.18632\/oncotarget.27706","volume":"11","author":"Vageli","year":"2020","journal-title":"Oncotarget"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neo.2016.04.007","volume":"18","author":"Sasaki","year":"2016","journal-title":"Neoplasia"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3390\/cells9041031","article-title":"A tobacco smoke carcinogen, on the miRNA and mismatch DNA repair expression profiles in lung and head and neck squamous cancer cells","volume":"9","author":"Doukas","year":"2020","journal-title":"Cells"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1111\/jcmm.13591","article-title":"NF-\u03baB inhibition reverses acidic bile-induced miR-21, miR-155, miR-192, miR-34a, miR-375 and miR-451a deregulations in human hypopharyngeal cells","volume":"22","author":"Doukas","year":"2018","journal-title":"J Cell Mol Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.3390\/curroncol29080437","volume":"29","author":"Doukas","year":"2022","journal-title":"Curr Oncol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/1471-2164-15-686","article-title":"Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing","volume":"15","author":"Agrawal","year":"2014","journal-title":"BMC Genomics"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41419-020-03150-0","article-title":"The HIF1\u03b1\/HIF2\u03b1-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"key":"ref57","first-page":"1759","article-title":"The HIF-1\u03b1\/miR-224-3p\/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia-induced protective autophagy in glioblastoma and astrocytoma","volume":"41","author":"Huang","year":"2019","journal-title":"Oncol Rep"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/labinvest.3700482","article-title":"Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion","volume":"86","author":"Zagzag","year":"2006","journal-title":"Lab Invest"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"15705","DOI":"10.18632\/oncotarget.24594","article-title":"Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas","volume":"9","author":"Tsai","year":"2018","journal-title":"Oncotarget"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.humpath.2006.07.020","article-title":"Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX","volume":"38","author":"Korkolopoulou","year":"2007","journal-title":"Hum Pathol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/neup.12111","article-title":"Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1\u03b1 in human glioblastoma","volume":"34","author":"Clara","year":"2014","journal-title":"Neuropathology"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1440-1789.2005.00632.x","article-title":"Prognostic significance of microvessel density determined by an anti-CD105\/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody","volume":"25","author":"Yao","year":"2005","journal-title":"Neuropathology"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.18632\/oncotarget.141","article-title":"VEGF-independent angiogenic pathways induced by PDGF-C","volume":"1","author":"Li","year":"2010","journal-title":"Oncotarget"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3892\/ijo.2022.5462","article-title":"Modulatory activity of ADNP on the hypoxia\u2010induced angiogenic process in glioblastoma","volume":"62","author":"D\u2019Amico","year":"2023","journal-title":"Int J Oncol"},{"key":"ref65","first-page":"1614336","article-title":"Hypoxia-driven M2-polarized macrophages facilitate cancer aggressiveness and temozolomide resistance in glioblastoma","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1742-2094-8-32","article-title":"Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma","volume":"8","author":"Tafani","year":"2011","journal-title":"J Neuroinflammati"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11010-006-9275-7","article-title":"Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival","volume":"295","author":"Perdiki","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1158\/0008-5472.CAN-07-0141","article-title":"EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1\/Sp3 transcription factors in human gliomas","volume":"67","author":"Xu","year":"2007","journal-title":"Cancer Res"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/glia.20800","article-title":"Oct4 is expressed in human gliomas and promotes colony formation in glioma cells","volume":"57","author":"Du","year":"2009","journal-title":"Glia"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","article-title":"Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells","volume":"15","author":"Li","year":"2009","journal-title":"Cancer Cell"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10014-014-0203-3","article-title":"Oct-3\/4 promotes tumor angiogenesis through VEGF production in glioblastoma","volume":"32","author":"Takahashi","year":"2015","journal-title":"Brain Tumor Pathol"},{"key":"ref72","first-page":"1541","article-title":"Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1101\/gad.14.4.391","article-title":"Loss of PTEN facilitates HIF-1-mediated gene expression","volume":"14","author":"Zundel","year":"2000","journal-title":"Genes Dev"},{"key":"ref74","first-page":"2742","volume":"63","author":"Choe","year":"2003","journal-title":"Cancer Res"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"e86102","DOI":"10.1371\/journal.pone.0086102","article-title":"The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1871520615666150824153032","article-title":"CXCR4 and glioblastoma","volume":"16","author":"Richardson","year":"2016","journal-title":"Anticancer Agents Med Chem"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1227\/01.NEU.0000324896.26088.EF","article-title":"CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities","volume":"63","author":"Stevenson","year":"2008","journal-title":"Neurosurgerg"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3580","article-title":"Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology","volume":"13","author":"Hallberg","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.biopha.2018.05.079","article-title":"Overexpression of STAT1 suppresses angiogenesis under hypoxia by regulating VEGF-A in human glioma cells","volume":"104","author":"Zhang","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11060-016-2350-3","article-title":"Assessment of vascularity in glioblastoma and its implications on patient outcomes","volume":"132","author":"McGahan","year":"2017","journal-title":"J Neurooncol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1093\/nar\/gkv278","article-title":"RefSeq microbial genomes database: new representation and annotation strategy","volume":"43","author":"Tatusova","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00259-017-3677-5","article-title":"[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis","volume":"44","author":"Bekaert","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/cancers11010041","article-title":"Epilepsy associates with decreased HIF-1\u03b1\/STAT5b signaling in glioblastoma","volume":"11","author":"Berendsen","year":"2019","journal-title":"Cancers"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0959-8049(97)00374-2","article-title":"Prevalence and prognostic significance of epilepsy in patients with gliomas","volume":"34","author":"Lote","year":"1998","journal-title":"Eur J Cancer"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s12149-015-0951-0","volume":"29","author":"Beppu","year":"2015","journal-title":"Ann Nucl Med"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11307-013-0670-7","article-title":"Standardized uptake value in high uptake area on positron emission tomography with 18F-FRP170 as a hypoxic cell tracer correlates with intratumoral oxygen pressure in glioblastoma","volume":"16","author":"Beppu","year":"2014","journal-title":"Mol Imaging Biol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3171\/2009.10.JNS09510","volume":"113","author":"Shibahara","year":"2010","journal-title":"J Neurosurg"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.nucmedbio.2013.05.004","volume":"40","author":"Belloli","year":"2013","journal-title":"Nucl Med Biol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-009-9827-2","article-title":"Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target","volume":"92","author":"Jensen","year":"2009","journal-title":"J Neurooncol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"e000154","DOI":"10.1136\/bmjonc-2023-000154","article-title":"Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity","volume":"3","author":"Ortmann","year":"2024","journal-title":"BMJ Oncol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"15195","DOI":"10.1038\/s41598-020-72290-2","article-title":"Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor","volume":"10","author":"Renfrow","year":"2020","journal-title":"Sci Rep"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13046-020-01641-8","article-title":"Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma","volume":"39","author":"Liu","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ijc.11662","article-title":"Differential regulation of VEGF, HIF1alpha and angiopoietin-1, -2 and -4 by hypoxia and ionizing radiation in human glioblastoma","volume":"108","author":"Lund","year":"2004","journal-title":"Int J Cancer"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"796029","DOI":"10.1155\/2013\/796029","volume":"2013","author":"Chandrasekaran","year":"2013","journal-title":"Sci World J"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1186\/s12885-023-11625-4","volume":"23","author":"Senrung","year":"2023","journal-title":"BMC Cancer"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"e005583","DOI":"10.1136\/jitc-2022-005583","article-title":"Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice","volume":"11","author":"Dong","year":"2023","journal-title":"J Immunother Cancer"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/2772432817666220517163609","article-title":"Efficacy of anti-VEGF drugs based combination therapies in recurrent glioblastoma: systematic review and meta-analysis","volume":"19","author":"Solipuram","year":"2024","journal-title":"Curr Rev Clin Exp Pharmacol"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11912-023-01417-1","article-title":"Antiangiogenic therapy for malignant brain tumors: does it still matter?","volume":"25","author":"Pellerino","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/07357907.2023.2174261","article-title":"Efficacy and safety of bevacizumab for treating glioblastoma: a systematic review and meta-analysis of phase II and III randomized controlled trials","volume":"41","author":"Xie","year":"2023","journal-title":"Cancer Invest"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3390\/cancers15030830","article-title":"Exploring the past, present, and future of anti-angiogenic therapy in glioblastoma","volume":"15","author":"Zhang","year":"2023","journal-title":"Cancers"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/sj.bjc.6605412","article-title":"Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study","volume":"101","author":"Reardon","year":"2009","journal-title":"Br J Cancer"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"52423","DOI":"10.18632\/oncotarget.9387","article-title":"Histopathological investigation of glioblastomas resected under bevacizumab treatment","volume":"7","author":"Tamura","year":"2016","journal-title":"Oncotarget"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00432-004-0642-z","article-title":"Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1\u03b1)\/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cells","volume":"131","author":"Kamiyama","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1016\/j.wneu.2018.08.080","article-title":"Aspirin affects tumor angiogenesis and sensitizes human glioblastoma endothelial cells to temozolomide, bevacizumab, and sunitinib, impairing vascular endothelial growth factor-related signaling","volume":"120","author":"Navone","year":"2018","journal-title":"World Neurosurg"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejphar.2017.03.031","article-title":"Treatment of novel IL17A inhibitor in glioblastoma implementing 3rd generation co-culture cell line and patient-derived tumor model","volume":"803","author":"Khan","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.imlet.2004.11.012","article-title":"Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells","volume":"98","author":"Takahashi","year":"2005","journal-title":"Immunol Lett"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/jnen\/nlx088","article-title":"LBH589 inhibits glioblastoma growth and angiogenesis through suppression of HIF-1\u03b1 expression","volume":"76","author":"Yao","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"42408","DOI":"10.18632\/oncotarget.9878","article-title":"Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis","volume":"7","author":"Lin","year":"2016","journal-title":"Oncotarget"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/0008-5472.CAN-15-2951","article-title":"CRLX101, a nanoparticle-drug conjugate containing camptothecin, improves rectal cancer chemoradiotherapy by inhibiting DNA repair and HIF1\u03b1","volume":"77","author":"Tian","year":"2017","journal-title":"Cancer Res"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/neuonc\/nos337","article-title":"Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007","volume":"15","author":"Towner","year":"2013","journal-title":"Neuro Oncol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tranon.2018.10.002","article-title":"OKN-007 increases temozolomide (tmz) sensitivity and suppresses TMZ-resistant glioblastoma (GBM) tumor growth","volume":"12","author":"Towner","year":"2019","journal-title":"Transl Oncol"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"889971","DOI":"10.3389\/fmolb.2022.889971","article-title":"Thioredoxin reductase inhibitors as potential antitumors: mercury compounds efficacy in glioma cells","volume":"9","author":"Pires","year":"2022","journal-title":"Front Mol Biosci"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"116844","DOI":"10.1016\/j.taap.2024.116844","article-title":"Exposure of human glioblastoma cells to thimerosal inhibits the thioredoxin system and decreases tumor growth-related factors","volume":"484","author":"Bramatti","year":"2024 Mar","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1476-4598-9-133","volume":"9","author":"M\u00e9ndez","year":"2010","journal-title":"Mol Cancer"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3171\/2014.10.JNS132363","article-title":"RNA interference targeting hypoxia-inducible factor 1\u03b1 via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model","volume":"122","author":"Gillespie","year":"2015","journal-title":"J Neurosurg"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"1098482","DOI":"10.3389\/fcell.2023.1098482","article-title":"Roles of STAT3 in the pathogenesis and treatment of glioblastoma","volume":"11","author":"Fu","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"e16195","DOI":"10.1371\/journal.pone.0016195","article-title":"Hypoxia potentiates glioma-mediated immunosuppression","volume":"6","author":"Wei","year":"2011","journal-title":"PLoS One"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3892\/or.2014.3012","volume":"31","author":"Chen","year":"2014","journal-title":"Oncol Rep"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"e93264","DOI":"10.1371\/journal.pone.0093264","article-title":"Dexamethasone alleviates tumor-associated brain damage and angiogenesis","volume":"9","author":"Fan","year":"2014","journal-title":"PLoS One"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.22.00164","article-title":"NRG Oncology\/RTOG1205: a randomized phase II trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma","volume":"20;41","author":"Tsien","year":"2023","journal-title":"J Clin Oncol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11060-023-04456-7","article-title":"Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma","volume":"165","author":"Strowd","year":"2023 Oct","journal-title":"J Neurooncol"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/files\/or\/2024\/TSP_OR-32-8\/OncolRes-32-08-52130\/OncolRes-32-52130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T06:22:29Z","timestamp":1741242149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v32n8\/57317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":121,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024]]},"published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2024.052130","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}